PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC) trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Not yet recruitingThis early-stage trial tests a new drug called DA 3501 in people with advanced stomach or pancreatic cancers that have a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug shrinks tumors. About 51 adults will receive the drug every three we…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Blood filter aims to suck cancer cells out of patients with advanced tumors
Disease control Not yet recruitingThis study tests a device called ONCObind that filters blood to remove circulating tumor cells in patients with advanced pancreatic or colorectal cancer that has spread and is no longer responding to standard treatments. About 120 adults will receive the filter procedure multiple…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Bile drain before pancreatic surgery: help or hindrance?
Knowledge-focused Not yet recruitingThis study looks at whether draining bile before surgery for pancreatic cancer changes how the tumor behaves or how long patients live. Researchers will review medical records of 90 adults who had their pancreatic tumor removed over 8 years. No new treatments or procedures are gi…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Sponsor: East Lancashire Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 17, 2026 06:47 UTC
-
Genetic score may spot pancreatic cancer risk early
Knowledge-focused Not yet recruitingThis study looks at whether a genetic risk score can help predict who might get pancreatic cancer. Researchers will compare the DNA of people with and without the disease. The goal is to improve early detection and prevention strategies for this serious cancer.
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
Phase: NA • Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC